← Back to Search

STOMP for Chronic Pain (STOMP Trial)

N/A
Waitlist Available
Led By Jessica Merlin, MD PhD MBA
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Moderately severe and impairing chronic pain (PEG pain questionnaire = average of all three items is 4 or greater)
Chronic pain (Brief Chronic Pain Screening Questionnaire (BCPQ) = at least moderate pain for at least 3 months)
Must not have
Do not speak or understand English
Cannot attend the group sessions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up bpi will be conducted at baseline and immediately after the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to improve chronic pain treatment for people living with HIV, in accordance with the Department of Health and Human Services National Pain Strategy.

Who is the study for?
This trial is for English-speaking adults over 18 with chronic pain, specifically those living with HIV who experience moderate to severe pain lasting at least 3 months. Participants must be able to attend group sessions and not have major surgery planned that could interfere with the study.
What is being tested?
The STOMP intervention, a program designed to help manage chronic pain tailored for people living with HIV, is being tested against a comparison group. The goal is to see if STOMP can improve quality of life and health outcomes in this vulnerable population.
What are the potential side effects?
Since STOMP focuses on self-management skills rather than medication or invasive treatments, side effects are minimal but may include discomfort from discussing personal experiences or emotional fatigue related to participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience chronic pain that significantly affects my daily life.
Select...
I have been in moderate pain for at least 3 months.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot speak or understand English.
Select...
I am unable to attend group sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~bpi will be conducted at baseline and immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and bpi will be conducted at baseline and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Brief Pain Inventory (BPI) score immediately post intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Skills to Manage Pain (STOMP)Experimental Treatment1 Intervention
The intervention group will receive treatment as usual plus the STOMP behavioral intervention. The STOMP behavioral intervention consists of 12 intervention sessions (6 group and 6 individual sessions). The sessions will be completed over a period of 12-16 weeks from enrollment. The first intervention session will be a group session for all participants followed by individual and then alternating group and individual sessions for the rest of the intervention. The intervention group will utilize a study manual on pain management in which they will use with each session.
Group II: comparison groupActive Control1 Intervention
The comparison group will receive treatment as usual.The comparison group will also be provided with the intervention manual, however, no additional treatment will be provided to participants allocated to the control group. The group will not receive the PSM intervention.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,789 Previous Clinical Trials
16,359,343 Total Patients Enrolled
16 Trials studying Chronic Pain
128,668 Patients Enrolled for Chronic Pain
University of Alabama at BirminghamOTHER
1,647 Previous Clinical Trials
2,342,176 Total Patients Enrolled
7 Trials studying Chronic Pain
5,700 Patients Enrolled for Chronic Pain
National Institute of Mental Health (NIMH)NIH
2,921 Previous Clinical Trials
2,742,579 Total Patients Enrolled
4 Trials studying Chronic Pain
1,072 Patients Enrolled for Chronic Pain

Media Library

Skills TO Manage Pain (STOMP) Clinical Trial Eligibility Overview. Trial Name: NCT03692611 — N/A
Skills TO Manage Pain (STOMP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03692611 — N/A
Chronic Pain Clinical Trial 2023: Skills TO Manage Pain (STOMP) Highlights & Side Effects. Trial Name: NCT03692611 — N/A
Chronic Pain Research Study Groups: Skills to Manage Pain (STOMP), comparison group
~45 spots leftby Dec 2025